INC.

The New Super CJ Animated Series is Launching a Drawing Contest with Three $500 Prizes to Help Raise Awareness for Children’s Mental Health

by

HYATTSVILLE, Md., May 16, 2023 /PRNewswire/ — Super CJ, the strongest boy in the world, is launching a new drawing contest sponsored by the Epic Foundation with one $500 prize for each school level (elementary, junior high, and high school) to help raise awareness for children’s mental health. The contest invites participants to watch the … Read more

Hologic Announces Partnership with NFL Rookie Kelee Ringo and Family

by

MARLBOROUGH, Mass., May 16, 2023 /PRNewswire/ — Hologic, Inc. (Nasdaq: HOLX), a global leader in women’s health, announced a new partnership with recently drafted NFL cornerback Kelee Ringo and his mother, breast cancer survivor Tralee Hale, to educate women on the importance of prioritizing annual mammograms and other key health screenings. Ringo is a two-time … Read more

Inhibikase Therapeutics Announces Dosing of First Patient in its Phase 2 ‘201’ Clinical Trial of IkT-148009 to Treat Parkinson’s Disease

by

BOSTON and ATLANTA, May 16, 2023 /PRNewswire/ — Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase), a clinical-stage pharmaceutical company developing therapeutics to modify the course of Parkinson’s disease and related disorders, today announced that the first patient has been dosed in its Phase 2 ‘201’ trial evaluating IkT-148009, the Company’s novel Abelson Tyrosine Kinase, or c-Abl, … Read more

Palatin Reports Third Quarter Fiscal Year 2023 Financial Results and Provides Corporate Update

by

Phase 3 PL9643 Data in Patients with Dry Eye Disease Presented at KOL Event Analysis of Lead-In Population of Initial 120 Patients Showed Statistical Separation for Clinical Efficacy Across Multiple Signs and Symptoms of Dry Eye along with Excellent Patient Safety and Tolerability Final Data Expected Second Half Calendar Year 2023 Phase 2 Clinical Study … Read more

NRx Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Business Update

by

Enrollment continues in the Phase 2b/3 clinical trial evaluating NRX-101 in Suicidal Treatment-Resistant Bipolar Depression; data expected in 4Q 2023 National educational campaign launched to further accelerate enrollment in Breakthrough Therapy Designation meeting for NRX-101 in Suicidal Treatment-Resistant Bipolar Depression with the U.S. FDA planned for 2Q 2023; on track to report topline clinical data … Read more

Nuclear Medicine Market to be Worth $22.3 Billion by 2030: Grand View Research, Inc.

by

SAN FRANCISCO, May 16, 2023 /PRNewswire/ – The global nuclear medicine market size is expected to reach USD 22.3 billion by 2030, registering a CAGR of 11.8% over the forecast period, according to a new report by Grand View Research, Inc. The increasing prevalence of chronic diseases such as cancer & thyroid is anticipated to drive … Read more

NUTEX HEALTH TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

by

HOUSTON, May 16, 2023 /PRNewswire/ — Nutex Health Inc. (“Nutex Health” or the “Company”) (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 19 state-of-the-art micro hospitals in 8 states and primary care-centric, risk-bearing physician networks, today announced that leadership is participating at the following investor conferences: RBC Global Healthcare ConferenceDate:  May 16, … Read more

INVO Reports First Quarter 2023 Financial Results

by

Company to Host Conference Call Today at 4:30pm ET SARASOTA, Fla., May 15, 2023 /PRNewswire/ — INVO Bioscience, Inc. (Nasdaq: INVO) (“INVO” or the “Company”), a commercial-stage fertility company focused on expanding access to advanced treatment worldwide with its INVOcell® medical device and the intravaginal culture (“IVC”) procedure it enables, today announced financial results for … Read more

Champions for Children

by

Lorestry announces global partners search CONCORD, Mass., May 15, 2023 /PRNewswire/ — Lorestry, by Alea Diagnostics (Alea) has just announced their search for mission-driven global partners committed to high quality health outcomes for newborns, children, and families. The pediatric nurse-led company is a trusted data gathering and developmental care navigation resource for parents, and is … Read more

NUTEX HEALTH REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS

by

NET REVENUE OF $56.3 MILLION NET CASH FROM OPERATING ACTIVITIES OF $1.1 MILLION  COMPANY EXPECTS TO OPEN 4-5 MORE HOSPITALS IN 2023 AND ANOTHER 14 BY END OF 2025 HOUSTON, May 15, 2023 /PRNewswire/ — Nutex Health Inc. (“Nutex Health” or the “Company”) (NASDAQ: NUTX), a physician-led, technology-enabled integrated healthcare delivery system comprised of 19 … Read more